A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61K 31/00 (2006.01) A61K 31/485 (2006.01)
Patent
CA 2449175
Methods for treating opioid-induced immune suppression with peripheral opioid antagonists are provided. In one embodiment, the method involves administering methylnaltrexone. Pharmaceutical compositions comprising an opioid, an opioid antagonist, and a pharmaceutical agent are also provided.
L'invention se rapporte à des procédés de traitement de l'immunodépression provoquée par des opioïdes au moyen d'antagonistes des opioïdes périphériques. Selon un mode de réalisation, le procédé consiste à administrer de la méthylnaltrexone. L'invention a également trait à des compositions pharmaceutiques comprenant un opioïde, un antagoniste des opioïdes et un agent pharmaceutique.
Moss Jonathan
Yuan Chun-Su
Smart & Biggar
University Of Chicago
LandOfFree
Use of methylnaltrexone to treat immune suppression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of methylnaltrexone to treat immune suppression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of methylnaltrexone to treat immune suppression will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1939827